NDLI: Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols

Content Provider	PubMed Central
Author	Ikebe, Chiho Suzuki, Ken
Copyright Year	2014
Abstract	Administration of bone marrow-derived mesenchymal stem cells (MSCs) is an innovative approach for the treatment of a range of diseases that are not curable by current therapies including heart failure. A number of clinical trials have been completed and many others are ongoing; more than 2,000 patients worldwide have been administered with culture-expanded allogeneic or autologous MSCs for the treatment of various diseases, showing feasibility and safety (and some efficacy) of this approach. However, protocols for isolation and expansion of donor MSCs vary widely between these trials, which could affect the efficacy of the therapy. It is therefore important to develop international standards of MSC production, which should be evidence-based, regulatory authority-compliant, of good medical practice grade, cost-effective, and clinically practical, so that this innovative approach becomes an established widely adopted treatment. This review article summarizes protocols to isolate and expand bone marrow-derived MSCs in 47 recent clinical trials of MSC-based therapy, which were published after 2007 onwards and provided sufficient methodological information. Identified issues and possible solutions associated with the MSC production methods, including materials and protocols for isolation and expansion, are discussed with reference to relevant experimental evidence with aim of future clinical success of MSC-based therapy.
Related Links	http://dx.doi.org/10.1155/2014/951512
Starting Page	951512
File Format	PDF
ISSN	23146133
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2014
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2014-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy

Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management

Among mesenchymal stem cells: for the best therapy after ischemic stroke

Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury

Allogeneic mesenchymal stem cells for treatment of severe burn injury

Regenerative Medicine for the Kidney: Renotropic Factors, Renal Stem/Progenitor Cells, and Stem Cell Therapy

Manipulated mesenchymal stem cell therapy in the treatment of Parkinson’s disease

Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases

Mesenchymal stem cell therapy for liver transplantation: clinical progress and immunomodulatory properties

Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols

Similar Documents

Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy

Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management

Among mesenchymal stem cells: for the best therapy after ischemic stroke

Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury

Allogeneic mesenchymal stem cells for treatment of severe burn injury

Regenerative Medicine for the Kidney: Renotropic Factors, Renal Stem/Progenitor Cells, and Stem Cell Therapy

Manipulated mesenchymal stem cell therapy in the treatment of Parkinson’s disease

Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases

Mesenchymal stem cell therapy for liver transplantation: clinical progress and immunomodulatory properties

Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols